These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 24731540)
21. Synthesis of ester prodrugs of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) as anti-poxvirus agents. Krecmerová M; Holý A; Andrei G; Pomeisl K; Tichý T; Brehová P; Masojídková M; Dracínský M; Pohl R; Laflamme G; Naesens L; Hui H; Cihlar T; Neyts J; De Clercq E; Balzarini J; Snoeck R J Med Chem; 2010 Oct; 53(19):6825-37. PubMed ID: 20809641 [TBL] [Abstract][Full Text] [Related]
22. Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs. Luo M; Groaz E; Andrei G; Snoeck R; Kalkeri R; Ptak RG; Hartman T; Buckheit RW; Schols D; De Jonghe S; Herdewijn P J Med Chem; 2017 Jul; 60(14):6220-6238. PubMed ID: 28682067 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of herpesvirus replication by hexadecyloxypropyl esters of purine- and pyrimidine-based phosphonomethoxyethyl nucleoside phosphonates. Prichard MN; Hartline CB; Harden EA; Daily SL; Beadle JR; Valiaeva N; Kern ER; Hostetler KY Antimicrob Agents Chemother; 2008 Dec; 52(12):4326-30. PubMed ID: 18852272 [TBL] [Abstract][Full Text] [Related]
24. Synthesis of fluorinated acyclic nucleoside phosphonates with 5-azacytosine base moiety. Pomeisl K; Krečmerová M; Pohl R; Snoeck R; Andrei G Tetrahedron; 2019 Sep; 75(39):130529. PubMed ID: 32287433 [TBL] [Abstract][Full Text] [Related]
25. In vitro evaluation of the anti-orf virus activity of alkoxyalkyl esters of CDV, cCDV and (S)-HPMPA. Dal Pozzo F; Andrei G; Lebeau I; Beadle JR; Hostetler KY; De Clercq E; Snoeck R Antiviral Res; 2007 Jul; 75(1):52-7. PubMed ID: 17184854 [TBL] [Abstract][Full Text] [Related]
26. Evolution of an amino acid based prodrug approach: stay tuned. Krylov IS; Kashemirov BA; Hilfinger JM; McKenna CE Mol Pharm; 2013 Feb; 10(2):445-58. PubMed ID: 23339402 [TBL] [Abstract][Full Text] [Related]
27. Aryl ester prodrugs of cyclic HPMPC. I: Physicochemical characterization and in vitro biological stability. Oliyai R; Shaw JP; Sueoka-Lennen CM; Cundy KC; Arimilli MN; Jones RJ; Lee WA Pharm Res; 1999 Nov; 16(11):1687-93. PubMed ID: 10571273 [TBL] [Abstract][Full Text] [Related]
28. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines. De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948 [TBL] [Abstract][Full Text] [Related]
29. PMPA and PMEA prodrugs for the treatment of HIV infections and human papillomavirus (HPV) associated neoplasia and cancer. Pertusati F; Hinsinger K; Flynn ÁS; Powell N; Tristram A; Balzarini J; McGuigan C Eur J Med Chem; 2014 May; 78():259-68. PubMed ID: 24686012 [TBL] [Abstract][Full Text] [Related]
30. Influence of intravitreal injections of HPMPC and related nucleoside analogues on intraocular pressure in guinea pig eyes. Banker AS; De Clercq E; Taskintuna I; Keefe KS; Bergeron-Lynn G; Freeman WR Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1233-42. PubMed ID: 9620084 [TBL] [Abstract][Full Text] [Related]
31. New prodrugs of Adefovir and Cidofovir. Tichý T; Andrei G; Dračínský M; Holý A; Balzarini J; Snoeck R; Krečmerová M Bioorg Med Chem; 2011 Jun; 19(11):3527-39. PubMed ID: 21565516 [TBL] [Abstract][Full Text] [Related]
32. Synthesis, metabolic stability and antiviral evaluation of various alkoxyalkyl esters of cidofovir and 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine. Ruiz J; Beadle JR; Buller RM; Schreiwer J; Prichard MN; Keith KA; Lewis KC; Hostetler KY Bioorg Med Chem; 2011 May; 19(9):2950-8. PubMed ID: 21493074 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of salicylate ester prodrugs of cyclic HPMPC in dogs. Oliyai R; Arimilli MN; Jones RJ; Lee WA Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1411-4. PubMed ID: 11563033 [TBL] [Abstract][Full Text] [Related]
34. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions. Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155 [TBL] [Abstract][Full Text] [Related]
35. Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication. Neyts J; De Clercq E Biochem Pharmacol; 1994 Jan; 47(1):39-41. PubMed ID: 8311844 [TBL] [Abstract][Full Text] [Related]
36. Activities of alkoxyalkyl esters of cidofovir (CDV), cyclic CDV, and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against orthopoxviruses in cell monolayers and in organotypic cultures. Lebeau I; Andrei G; Dal Pozzo F; Beadle JR; Hostetler KY; De Clercq E; van den Oord J; Snoeck R Antimicrob Agents Chemother; 2006 Jul; 50(7):2525-9. PubMed ID: 16801436 [TBL] [Abstract][Full Text] [Related]
37. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides. Magee WC; Evans DH Antiviral Res; 2012 Nov; 96(2):169-80. PubMed ID: 22960154 [TBL] [Abstract][Full Text] [Related]
38. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro. Williams-Aziz SL; Hartline CB; Harden EA; Daily SL; Prichard MN; Kushner NL; Beadle JR; Wan WB; Hostetler KY; Kern ER Antimicrob Agents Chemother; 2005 Sep; 49(9):3724-33. PubMed ID: 16127046 [TBL] [Abstract][Full Text] [Related]
39. [Design, synthesis and anti-hBV evaluation of adefovir mono-L-amino acid ester, mono non-steroidal anti-inflammatory drugs carboxylic ester prodrugs]. Fu XZ; Wang YL; Lan YY; Wang AM; Ou Y; Luo C; Li Y Yao Xue Xue Bao; 2010 Aug; 45(8):1017-24. PubMed ID: 21351588 [TBL] [Abstract][Full Text] [Related]